One Tysabri PML patient deteriorates, one improves
(Reuters)
Unusual Little Blurbs
Reuters - One of two patients who developed a
potentially deadly brain infection after taking the multiple
sclerosis drug Tysabri is deteriorating, while one is
recovering, according to a researcher involved in their care.
Source: Yahoo! News: Biotechnology News
Elan pledges royalties-linked dividend
Drug company offers to pay shareholders a share of future royalties on its multiple sclerosis drug Tysabri in an effort to counter takeover bid
Source: Pharmaceuticals companies news from the Financial Times